Team:Penn/Project2
From 2013.igem.org
(9 intermediate revisions not shown) | |||
Line 14: | Line 14: | ||
.figure { | .figure { | ||
display: inline-block; | display: inline-block; | ||
- | + | height: 50px; | |
- | margin | + | margin: auto; |
- | margin- | + | margin-left: 0px; |
- | margin- | + | margin-right:20px; |
margin-bottom: 10px; | margin-bottom: 10px; | ||
} | } | ||
+ | |||
Line 34: | Line 35: | ||
<ul class="navbar"> | <ul class="navbar"> | ||
- | <li><a href="https://2013.igem.org/Team:Penn"> | + | <li><a href="https://2013.igem.org/Team:Penn">HOME</a></li> |
<li class="dropdown" id="project"> | <li class="dropdown" id="project"> | ||
- | <a href="#" class="active" data-toggle="dropdown"> | + | <a href="#" class="active" data-toggle="dropdown">PROJECT<div class="arrow">></div> <b class="caret"></b></a> |
<ul class="dropdown-menu" id="drop-menu1"> | <ul class="dropdown-menu" id="drop-menu1"> | ||
Line 46: | Line 47: | ||
</li> | </li> | ||
<li class="dropdown" id="about"> | <li class="dropdown" id="about"> | ||
- | <a href="#" class="dropdown-toggle" data-toggle="dropdown"> | + | <a href="#" class="dropdown-toggle" data-toggle="dropdown">ABOUT<div class="arrow">></div> <b class="caret"></b></a> |
<ul class="dropdown-menu" id="drop-menu2"> | <ul class="dropdown-menu" id="drop-menu2"> | ||
<li><a href="https://2013.igem.org/Team:Penn/Team">team</a></li> | <li><a href="https://2013.igem.org/Team:Penn/Team">team</a></li> | ||
Line 53: | Line 54: | ||
</li></ul> | </li></ul> | ||
- | <li><a href="https://2013.igem.org/Team:Penn/HumanPractices"> | + | <li><a href="https://2013.igem.org/Team:Penn/HumanPractices">HUMAN PRACTICES</a></li> |
- | <li><a href="https://2013.igem.org/Team:Penn/Notebook"> | + | <li><a href="https://2013.igem.org/Team:Penn/Notebook">NOTEBOOK</a></li> |
</ul> | </ul> | ||
Line 68: | Line 69: | ||
<div class="content2"> | <div class="content2"> | ||
- | <h2> | + | <h2>ABSTRACT</h2> |
<p>The code of life is much more than a sequence of A's, G's, C's and T's; | <p>The code of life is much more than a sequence of A's, G's, C's and T's; | ||
a suite of epigenetic mechanisms, ranging from chromatin remodeling to non-coding RNAs, | a suite of epigenetic mechanisms, ranging from chromatin remodeling to non-coding RNAs, | ||
- | affect gene expression and cellular function. <div class="figure-wrap"><img class="figure" src="https://googledrive.com/host/0B4ZBZOYYKBzEeG5XLTdURjc0aTA" "/> | + | affect gene expression and cellular function. <div class="figure-wrap" style="margin-left: 200px;"><img class="figure" src="https://googledrive.com/host/0B4ZBZOYYKBzEeG5XLTdURjc0aTA" "/> |
<img class="figure" src="https://googledrive.com/host/0B4ZBZOYYKBzEeG05enR0ZFFXeEE" /> | <img class="figure" src="https://googledrive.com/host/0B4ZBZOYYKBzEeG05enR0ZFFXeEE" /> | ||
<img class="figure" src="https://googledrive.com/host/0B4ZBZOYYKBzEXzVMY3EtX284cTA" /></div> | <img class="figure" src="https://googledrive.com/host/0B4ZBZOYYKBzEXzVMY3EtX284cTA" /></div> | ||
- | + | <p> In particular, DNA methylation has been | |
shown to alter transcriptional activity in a powerful, heritable manner. Abnormal methylation | shown to alter transcriptional activity in a powerful, heritable manner. Abnormal methylation | ||
patterns are associated with diseases including immunodeficiency syndromes, neurodevelopmental | patterns are associated with diseases including immunodeficiency syndromes, neurodevelopmental | ||
Line 85: | Line 86: | ||
but the tools don’t exist to easily manipulate epigenetic patterns. We are developing a novel | but the tools don’t exist to easily manipulate epigenetic patterns. We are developing a novel | ||
fusion protein that enables site-specific methylation, which can repress promoter activity with | fusion protein that enables site-specific methylation, which can repress promoter activity with | ||
- | high precision. <div class="figure-wrap" style="float: center;"><img src="https://googledrive.com/host/0B4ZBZOYYKBzEdmZMalozd0pkSjg" style="height: 75px;"/> | + | high precision. <div class="figure-wrap" style="float: center;"><img src="https://googledrive.com/host/0B4ZBZOYYKBzEdmZMalozd0pkSjg" style="height: 75px; margin: 5px; float: left;"/> |
- | <img src="https://googledrive.com/host/0B4ZBZOYYKBzEdlExOEgtVlZYYUU" style="height: 75px; float: | + | <img src="https://googledrive.com/host/0B4ZBZOYYKBzEdlExOEgtVlZYYUU" style="height: 75px; float: left; margin: 5px;"/></div><p>In coming years, this fusion protein could become a powerful tool for epigenetics |
researchers looking to perform on/off studies in the vein of classical genetics, as well as an | researchers looking to perform on/off studies in the vein of classical genetics, as well as an | ||
orthogonal mode of repressing constitutive promoters for bacterial synthetic biologists. | orthogonal mode of repressing constitutive promoters for bacterial synthetic biologists. | ||
Eventually, it could even give clinical researchers the means to restore healthy methylation | Eventually, it could even give clinical researchers the means to restore healthy methylation | ||
levels in many insofar-untreatable epigenetic diseases.</p> | levels in many insofar-untreatable epigenetic diseases.</p> | ||
- | <img src="https://googledrive.com/host/0B4ZBZOYYKBzEMzM5dWpRQWNvb1k" style="height: | + | <img src="https://googledrive.com/host/0B4ZBZOYYKBzEMzM5dWpRQWNvb1k" style="height: 75px; display: inline; float: right; margin: 5px;"/> |
- | <img src="https://googledrive.com/host/0B4ZBZOYYKBzEek95VVUyMkltSHc" style="height: | + | <img src="https://googledrive.com/host/0B4ZBZOYYKBzEek95VVUyMkltSHc" style="height: 75px; float: right; margin: 5px; "/> |
</div> | </div> | ||
Line 102: | Line 103: | ||
$(".dropdown").mouseenter(function(){ | $(".dropdown").mouseenter(function(){ | ||
+ | $(".dropdown-menu").hide(); | ||
$(this).find(".dropdown-menu").show(); | $(this).find(".dropdown-menu").show(); | ||
}); | }); | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
$(".dropdown li").mouseenter(function(){ | $(".dropdown li").mouseenter(function(){ | ||
$(this).addClass("active"); | $(this).addClass("active"); |
Latest revision as of 20:19, 11 August 2013
ABSTRACT
The code of life is much more than a sequence of A's, G's, C's and T's; a suite of epigenetic mechanisms, ranging from chromatin remodeling to non-coding RNAs, affect gene expression and cellular function.
In particular, DNA methylation has been shown to alter transcriptional activity in a powerful, heritable manner. Abnormal methylation patterns are associated with diseases including immunodeficiency syndromes, neurodevelopmental disorders, and many types of cancer. Comprehensive understanding and control of DNA methylation could be invaluable to researchers studying these diseases.
Synthetic biologists and geneticists are accustomed to turning genes on and off at will, but the tools don’t exist to easily manipulate epigenetic patterns. We are developing a novel fusion protein that enables site-specific methylation, which can repress promoter activity with high precision.
In coming years, this fusion protein could become a powerful tool for epigenetics researchers looking to perform on/off studies in the vein of classical genetics, as well as an orthogonal mode of repressing constitutive promoters for bacterial synthetic biologists. Eventually, it could even give clinical researchers the means to restore healthy methylation levels in many insofar-untreatable epigenetic diseases.